AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 20.17 USD -2.8% Market Closed
Market Cap: 608.7m USD
Have any thoughts about
AnaptysBio Inc?
Write Note

AnaptysBio Inc
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AnaptysBio Inc
Accrued Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
AnaptysBio Inc
NASDAQ:ANAB
Accrued Liabilities
$40.3m
CAGR 3-Years
38%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Accrued Liabilities
$14.6B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Accrued Liabilities
$2.5B
CAGR 3-Years
7%
CAGR 5-Years
25%
CAGR 10-Years
24%

See Also

What is AnaptysBio Inc's Accrued Liabilities?
Accrued Liabilities
40.3m USD

Based on the financial report for Sep 30, 2024, AnaptysBio Inc's Accrued Liabilities amounts to 40.3m USD.

What is AnaptysBio Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 5Y
20%

Over the last year, the Accrued Liabilities growth was 23%. The average annual Accrued Liabilities growth rates for AnaptysBio Inc have been 38% over the past three years , 20% over the past five years .

Back to Top